Solid Biosciences Inc.
SLDB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $163,268 | $122,088 | $45,795 | $186,848 |
| - Cash | $80,235 | $74,015 | $155,384 | $119,136 |
| + Debt | $24,177 | $26,265 | $28,547 | $2,063 |
| Enterprise Value | $107,210 | $74,338 | -$81,042 | $69,775 |
| Revenue | $0 | $0 | $8,094 | $13,620 |
| % Growth | – | -100% | -40.6% | – |
| Gross Profit | -$2,455 | -$2,581 | $8,094 | $13,620 |
| % Margin | – | – | 100% | 100% |
| EBITDA | -$121,902 | -$93,434 | -$96,866 | -$69,290 |
| % Margin | – | – | -1,196.8% | -508.7% |
| Net Income | -$124,697 | -$96,015 | -$85,981 | -$72,188 |
| % Margin | – | – | -1,062.3% | -530% |
| EPS Diluted | -3.06 | -4.83 | -10.1 | -10.14 |
| % Growth | 36.6% | 52.2% | 0.4% | – |
| Operating Cash Flow | -$100,012 | -$94,180 | -$97,977 | -$77,764 |
| Capital Expenditures | -$654 | -$1,515 | -$3,015 | -$1,281 |
| Free Cash Flow | -$100,666 | -$95,695 | -$100,992 | -$79,045 |